Related Experiment Videos
The current state of hormonal therapy for prostate cancer
Beth A Hellerstedt1, Kenneth J Pienta
1Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA.
CA: a Cancer Journal for Clinicians
|May 23, 2002
Abstract:
Androgen deprivation therapy remains a mainstay of treatment for men with prostate cancer. New uses for hormonal therapy, including use in the adjuvant and neoadjuvant setting, are being evaluated. Prevention of the side effects of therapy has led to the development of alternative schedules and therapeutics.